Dr. Ron Adelman, MD, MPH, FACS at the Yale Eye Center reviews the results of a large study by the National Eye Institute (AREDS) that proposed an effective solution to stop the progression of age-related macular degeneration. The National Eye Institute is currently conducting a follow-up study (AREDS 2).
References and Resources
Age-Related Eye Disease Study Research group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch Ophthalmol. 2001;119(10):1417-1436.
Age-Related Eye Disease Study Research Group. The relationship of dietary carotenoid and vitamin A, E, and C intake with age-related macular degeneration in a case-control study: AREDS Report No. 22. Arch Ophthalmol. 2007;125(9):1225-1232.
SanGiovanni, J., et al. The relationship of dietary lipid intake and age-related macular degeneration in a case-control study: AREDS Report No. 20. Arch Ophthalmol. 2007;125(5):671-679.
Clemons, T., et al. Risk factors for the incidence of Advanced Age-Related Macular Degeneration in the Age-Related Eye Disease Study (AREDS) AREDS report no. 19. Ophthalmology. 2005;112(4):533-539.
For more information on Dr. Adelman and the Yale Eye Center, visit:
Sponsored by The Doctor’s Channel